Researchers and doctors from the University of Tartu and Tartu University Hospital evaluated the use of a novel revolutionary method, flow cytometry, for diagnosing urethritis in Estonian men. The study published in PLOS ONE confirmed the efficiency of the method and showed that most often urethritis was due to chlamydia. Gonorrhoea caused the strongest urethral inflammation.
A new research study from the March of Dimes Prematurity Research Center led by investigators at the University of Chicago has identified new genetic markers associated with gestational length, providing new insights into potential risk factors for preterm birth.
The number of people living with undiagnosed HIV is increasing in the WHO European Region. According to data published today by ECDC and the WHO/Europe, more than 136 000 people were newly diagnosed in 2019 - roughly 20% of these diagnoses were in the EU/EAA and 80% in the eastern part of the European Region. Every second HIV diagnosis (53%) happens at a late stage of the infection, when the immune system has already started to fail.
Sexually-active over-45s are at a high risk of contracting STIs because people do not want to talk about holder people having sex, a report has found.
Up to one-quarter of people who suffer child sexual abuse might be passed over for treatment because of current screening procedures, according to UC Riverside psychology researchers. Their just-published study also finds that whether survivors of child sexual abuse identify themselves as abuse survivors influences the outcomes they experience in young adulthood. The study surveyed 2,195 undergraduate college students.
Analyzing the elevated cognitive health risks among older members of the LGB community, this is the first study to use a national sample and screening tool to gauge cognitive health disparities between LGB and heterosexual older adults.
Scientists at a research center supported by FAPESP identified a non-inherited mutation in blood cells from a patient with GATA2 deficiency that may have prevented bone marrow failure and other clinical manifestations.
Transgender people who lack access to insurance coverage for gender-affirming hormone therapy are more likely to use hormones from sources other than a licensed prescriber, compared to those with insurance coverage.
People who are transgender and lack access to insurance coverage for gender-affirming hormone therapy are more likely to turn to sources other than a licensed health care provider, a new Michigan Medicine-led study finds.
New research examines the dynamics between men's health literacy, their discussions with their doctors, and their decisions on whether to get tested for prostate-specific antigen (PSA), a potential marker of prostate cancer. The findings are published early online in CANCER, a peer-reviewed journal of the American Cancer Society (ACS).